BAL PHARMA
Back to Cashflow Statement
|
BAL PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-7.84 Cr | ₹-1.21 Cr | ₹24 Cr | ₹-17 Cr | ₹-17 Cr |
What is the latest Cash Flow from Financing Activities ratio of BAL PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-7.84 Cr |
| Mar2024 | ₹-1.21 Cr |
| Mar2023 | ₹24 Cr |
| Mar2022 | ₹-17 Cr |
| Mar2021 | ₹-17 Cr |
How is Cash Flow from Financing Activities of BAL PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-7.84 Cr | Negative | |
| Mar2024 | ₹-1.21 Cr | Negative | |
| Mar2023 | ₹24 Cr | Positive | |
| Mar2022 | ₹-17 Cr | Negative | |
| Mar2021 | ₹-17 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹122.4 Cr | 1.3% | 14.8% | -22% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,613.0 Cr | 0.9% | 6.2% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,105.0 Cr | 1.8% | 4.8% | 6.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,926.0 Cr | 1.3% | 9.8% | 37.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,088.0 Cr | 1.7% | 5.8% | 6.7% | Stock Analytics | |
| CIPLA | ₹107,120.0 Cr | -1.3% | 0.9% | -8.9% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 1.3% |
14.8% |
-22% |
| SENSEX | 0% |
1.2% |
9.7% |
You may also like the below Video Courses